Cardiovascular Manifestations in Inflammatory Bowel Disease: A Systematic Review of the Pathogenesis and Management

Ravi S Patel1, Sai Rohit Reddy1, Adiona Llukmani1

  • 1Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Cureus
|April 22, 2021
PubMed

Insights

Pericarditis in inflammatory bowel disease (IBD) is often a drug complication, not an IBD manifestation. Management involves stopping offending medications or using corticosteroids.

Area of Science:

  • Gastroenterology
  • Cardiology
  • Immunology

Background:

  • Inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn's disease, is a chronic gastrointestinal disorder.
  • Pericarditis, inflammation of the heart's outer lining, is a rare but serious complication associated with IBD.
  • The exact cause of pericarditis in IBD patients remains debated: extraintestinal manifestation or drug-induced.

Purpose of the Study:

  • To elucidate the pathogenesis of pericarditis in IBD patients.
  • To determine if pericarditis is an extraintestinal manifestation or a drug-induced complication.
  • To outline the management strategies for pericarditis in IBD, including the role of biologics.

Main Methods:

  • Systematic electronic search for relevant reports on pericarditis in IBD.
  • Quality assessment of identified articles based on predefined inclusion criteria.
  • Inclusion of full-text articles published in English from inception to November 2020.

Main Results:

  • The majority of evidence suggests pericarditis in IBD is a complication of 5-aminosalicylic acid derivatives (e.g., sulfasalazine, mesalamine).
  • Mechanisms include IgE-mediated reactions, direct cardiac toxicity, cell-mediated hypersensitivity, and humoral antibody responses.
  • Pericarditis is rarely considered a direct extraintestinal manifestation of IBD itself.

Conclusions:

  • Pericarditis in IBD is predominantly linked to adverse drug reactions rather than being a direct disease manifestation.
  • Drug cessation or corticosteroid therapy are effective first-line treatments for drug-induced pericarditis in IBD.
  • Further research may clarify the role of biologics in preventing or managing pericarditis in this patient population.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
516
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
546
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
86
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
86
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
132
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
110